We just received data on a new analyst forecast for $FATE. Wedbush gave a rating of 'Outperform' for $FATE.
$FATE Analyst Ratings
Wall Street analysts have issued reports on $FATE in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wedbush issued a "Outperform" rating on 10/27/2025
- Barclays issued a "Overweight" rating on 05/14/2025
To track analyst ratings and price targets for $FATE, check out Quiver Quantitative's $FATE forecast page.
$FATE Price Targets
Multiple analysts have issued price targets for $FATE recently. We have seen 4 analysts offer price targets for $FATE in the last 6 months, with a median target of $3.25.
Here are some recent targets:
- David Nierengarten from Wedbush set a target price of $7.0 on 10/27/2025
- Yanan Zhu from Wells Fargo set a target price of $2.5 on 08/13/2025
- Peter Lawson from Barclays set a target price of $2.0 on 05/14/2025
- Jack Allen from Baird set a target price of $4.0 on 05/14/2025
$FATE Insider Trading Activity
$FATE insiders have traded $FATE stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $FATE stock by insiders over the last 6 months:
- BAHRAM VALAMEHR (President and CEO) sold 14,466 shares for an estimated $15,396
- CINDY TAHL (See Remarks) sold 9,037 shares for an estimated $9,572
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$FATE Hedge Fund Activity
We have seen 69 institutional investors add shares of $FATE stock to their portfolio, and 64 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SCHONFELD STRATEGIC ADVISORS LLC removed 6,863,704 shares (-88.1%) from their portfolio in Q2 2025, for an estimated $7,687,348
- JPMORGAN CHASE & CO removed 3,339,709 shares (-98.3%) from their portfolio in Q2 2025, for an estimated $3,740,474
- ORBIMED ADVISORS LLC removed 1,680,580 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $1,882,249
- VANGUARD GROUP INC removed 1,543,689 shares (-15.0%) from their portfolio in Q2 2025, for an estimated $1,728,931
- JACOBS LEVY EQUITY MANAGEMENT, INC removed 989,587 shares (-44.9%) from their portfolio in Q2 2025, for an estimated $1,108,337
- BAKER BROS. ADVISORS LP removed 773,384 shares (-23.7%) from their portfolio in Q2 2025, for an estimated $866,190
- WOODLINE PARTNERS LP removed 711,517 shares (-50.0%) from their portfolio in Q2 2025, for an estimated $796,899
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
